Alpha Cognition Inc
ACOG5.230USD
+0.170+3.36%
Handelsschluss 04/25, 16:00（ET）Kurse um 15 Minuten verzögert
83.78MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Alpha Cognition Inc Unternehmen
Alpha Cognition Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is engaged in developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company’s pipeline includes ALPHA-1062, ALPHA-0602, and ALPHA-0702 and ALPHA-0802 (GEMs). The Company’s ALPHA-1062 is a patented new chemical entity being developed as a new generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease, with expected minimal gastrointestinal side effects. ALPHA-1062 is also being developed in combination with memantine to treat moderate to severe Alzheimer’s dementia, and as an intranasal formulation for Cognitive Impairment with mTBI. ALPHA-0602 is a gene therapy program delivering progranulin, a neurotrophic protein. It is in preclinical development for the treatment of ALS.
Unternehmensinformationen
Unternehmens-codeACOG
Name des UnternehmensAlpha Cognition Inc
IPO-datumJun 09, 2021
Gegründet am2017
CEOMr. Michael Mcfadden
Anzahl der mitarbeiter52
WertpapierartOrdinary Share
GeschäftsjahresendeJun 09
Addressec/o 1200 - 750 West Pender Street
StadtVANCOUVER
BörseNASDAQ Capital Market Consolidated
LandCanada
PostleitzahlV6C 2T8
Telefon16045649244
Websitehttps://www.alphacognition.com/
Unternehmens-codeACOG
IPO-datumJun 09, 2021
Gegründet am2017
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Len Mertz
Mr. Len Mertz
Independent Chairman of the Board
Independent Chairman of the Board
223.53K
+2.40K%
Mr. Michael Mcfadden
Mr. Michael Mcfadden
Chief Executive Officer, Director
Chief Executive Officer, Director
11.53K
+2.40K%
Dr. Robert Wills
Dr. Robert Wills
Independent Director
Independent Director
--
--
Mr. Henry Du
Mr. Henry Du
Interim Chief Financial Officer, Vice President - Finance and Accounting
Interim Chief Financial Officer, Vice President - Finance and Accounting
--
--
Ms. Lauren D'Angelo
Ms. Lauren D'Angelo
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Kenneth A. (Ken) Cawkell
Mr. Kenneth A. (Ken) Cawkell
Corporate Secretary, Director
Corporate Secretary, Director
--
--
Mr. Rajeev (Rob) Bakshi
Mr. Rajeev (Rob) Bakshi
Independent Director
Independent Director
--
--
Mr. John Havens
Mr. John Havens
Independent Director
Independent Director
--
--
Mr. Phillip Mertz
Mr. Phillip Mertz
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Len Mertz
Mr. Len Mertz
Independent Chairman of the Board
Independent Chairman of the Board
223.53K
+2.40K%
Mr. Michael Mcfadden
Mr. Michael Mcfadden
Chief Executive Officer, Director
Chief Executive Officer, Director
11.53K
+2.40K%
Dr. Robert Wills
Dr. Robert Wills
Independent Director
Independent Director
--
--
Mr. Henry Du
Mr. Henry Du
Interim Chief Financial Officer, Vice President - Finance and Accounting
Interim Chief Financial Officer, Vice President - Finance and Accounting
--
--
Ms. Lauren D'Angelo
Ms. Lauren D'Angelo
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Kenneth A. (Ken) Cawkell
Mr. Kenneth A. (Ken) Cawkell
Corporate Secretary, Director
Corporate Secretary, Director
--
--
Umsatzaufteilung
Keine Daten
Keine Daten
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionäre
Update-Zeit: Thu, Apr 24
Update-Zeit: Thu, Apr 24
Aktionärsstatistik
Art
Aktionärsstatistik
Aktionäre
Anteil
Solas Capital Management, LLC
8.70%
AWM Investment Company, Inc.
6.58%
Cable Car Capital LLC
5.42%
Ikarian Capital LLC
4.72%
Sphera Funds Management Ltd.
3.87%
Other
70.72%
Aktionärsstatistik
Aktionäre
Anteil
Solas Capital Management, LLC
8.70%
AWM Investment Company, Inc.
6.58%
Cable Car Capital LLC
5.42%
Ikarian Capital LLC
4.72%
Sphera Funds Management Ltd.
3.87%
Other
70.72%
Art
Aktionäre
Anteil
Hedge Fund
31.49%
Investment Advisor/Hedge Fund
15.07%
Individual Investor
8.21%
Investment Advisor
2.23%
Corporation
1.38%
Bank and Trust
0.07%
Other
41.54%
Institutionelle Beteiligung
Update-Zeit: Tue, Apr 1
Update-Zeit: Tue, Apr 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q1
35
8.65M
54.08%
+8.55M
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Solas Capital Management, LLC
1.39M
8.7%
+1.39M
--
Dec 31, 2024
AWM Investment Company, Inc.
1.05M
6.58%
+1.05M
--
Dec 31, 2024
Cable Car Capital LLC
514.72K
3.21%
+514.72K
--
Dec 31, 2024
Ikarian Capital LLC
755.87K
4.72%
+755.87K
--
Dec 31, 2024
Sphera Funds Management Ltd.
620.00K
3.87%
+620.00K
--
Dec 31, 2024
Sio Capital Management, LLC
434.70K
2.71%
+434.70K
--
Dec 31, 2024
Alyeska Investment Group, L.P.
400.00K
2.5%
+400.00K
--
Dec 31, 2024
Manchester Management Company, L.L.C.
379.34K
2.37%
+364.17K
+2.40K%
Nov 13, 2024
Havens (John P)
285.59K
1.78%
+274.34K
+2.44K%
Nov 13, 2024
Altium Capital Management LP
275.00K
1.72%
+275.00K
--
Dec 31, 2024
Mehr Anzeigen
Verbundene ETFs
Name
Anteil
Keine Daten
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten